Canada Markets open in 8 hrs 2 mins

FSD Pharma Inc. (HUGE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0200-0.0100 (-0.97%)
At close: 04:00PM EST
1.0100 -0.01 (-0.98%)
After hours: 05:26PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.0300
Open1.0300
Bid0.0000 x 1000
Ask0.0000 x 1000
Day's Range1.0100 - 1.0300
52 Week Range0.9200 - 4.4400
Volume82,728
Avg. Volume265,826
Market Cap41.232M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-1.1340
Earnings DateMar. 15, 2022 - Mar. 21, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    FSD Pharma Announces Launch of New Corporate Website

    TORONTO, January 20, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company’s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. To vi

  • Business Wire

    FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada

    TORONTO, January 18, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, warmly congratulates Eleanor N. Fish, Ph.D., a member of its Research and Clinical Advisory Board, on her appointment to the Order of Canada.

  • Business Wire

    FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th

    TORONTO, January 04, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that Anthony Durkacz, Interim CEO of FSD Pharma, will present at the H.C. Wainwright Bioconnect Conference to be held virtually on January 10-13, 2022. Mr. Durkacz’s presentation will be available on-demand for conference attendees starting at 7:00 a.m. ET on January 10